SIRT5 reduces the inflammatory response and barrier dysfunction in IL-17A-induced epidermal keratinocytes

Main Article Content

Chunhui Wang
Danhua He
Cuiping Shi

Keywords

Dysfunction, Epidermal Barrier, ERK/STAT3, Inflammation, Proliferation, Psoriasis, SIRT5

Abstract

Psoriasis is a chronic multisystemic inflammatory disease with inflammatory cell infiltration, hyperproliferation of keratinocytes in skin lesions, and epidermal barrier dysfunction. Normal human epidermal keratinocytes (NHEKs) were stimulated with interleukin 17A (IL-17A). The expression levels of sirtuin-5 (SIRT5) were analyzed by RT-qPCR and western blot assay. The proliferation levels of NHEKs were assessed by EdU staining. The expression of ELOVL1 and ELOVL4 was analyzed by RT-Qpcr, and the expression levels of filaggrin, loricrin, and aquaporin-3 were analyzed by RT-qPCR and western blot. Extracellular signal-regulated kinase 1/2 (ERK1/2) activator t-butylhydroquinone was used to activate ERK1/2. Here, we show that SIRT5 overexpression reduces cell viability and cell proliferation, and improves barrier dysfunction in IL-17A-treated human epidermal keratinocytes, this effect of which is significantly blunted by the ERK1/2 activator. In epidermal keratinocytes, SIRT5 decreases cell proliferation and inflammation and improves barrier dysfunction via ERK/STAT3. This study reveals the role of SIRT5 in the pathogenesis of psoriasis, epidermal hyperplasia, keratinocyte-mediated inflammatory responses, and barrier dysfunction, the role of which is mediated by ERK/STAT3.

Abstract 86 | PDF Downloads 58 HTML Downloads 52 XML Downloads 5

References

1. Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997): 983–94. 10.1016/s0140-6736(14)61909-7

2. Basketter D, Darlenski R, Fluhr JW. Skin irritation and sensitization: Mechanisms and new approaches for risk assessment. Skin Pharmacol Physiol. 2008;21(4):191–202. 10.1159/000135635

3. Montero-Vilchez T, Segura-Fernández-Nogueras MV, Pérez-Rodríguez I, Soler-Gongora M, Martinez-Lopez A, Fernández-González A, et al. Skin barrier function in psoriasis and atopic dermatitis: Transepidermal water loss and temperature as useful tools to assess disease severity. J Clin Med. 2021;10(2):359. 10.3390/jcm10020359

4. Bieber T. Many ways lead to Rome: A glance at the multiple immunological pathways underlying atopic dermatitis. Allergy. 2013;68(8):957–8. 10.1111/all.12239

5. Montero-Vilchez T, Soler-Góngora M, Martínez-López A, Ana FG, Buendía-Eisman A, Molina-Leyva A, et al. Epidermal barrier changes in patients with psoriasis: The role of phototherapy. Photodermatol Photoimmunol Photomed. 2021; 37(4):285–92. 10.1111/phpp.12650

6. Correia M, Perestrelo T, Rodrigues AS, Ribeiro MF, Pereira SL, Sousa MI, et al. Sirtuins in metabolism, stemness and differentiation. Biochim Biophys Acta Gen Subj. 2017;1861(1 Pt A): 3444–55. 10.1016/j.bbagen.2016.09.008

7. Wu S, Wei Y, Li J, Bai Y, Yin P, Wang S. SIRT5 represses neurotrophic pathways and Aβ production in alzheimer's disease by targeting autophagy. ACS Chem Neurosci. 2021;12(23): 4428–37. 10.1021/acschemneuro.1c00468

8. Li W, Yang Y, Li Y, Zhao Y, Jiang H. Sirt5 attenuates cisplatin-induced acute kidney injury through regulation of Nrf2/HO-1 and Bcl-2. BioMed Res Int. 2019; 2019:4745132. 10.1155/2019/4745132

9. Wang Y, Zhu Y, Xing S, Ma P, Lin D. SIRT5 prevents cigarette smoke extract-induced apoptosis in lung epithelial cells via deacetylation of FOXO3. Cell Stress Chaperones. 2015;20(5):805–10. 10.1007/s12192-015-0599-7

10. Fan X, Yan K, Meng Q, Sun R, Yang X, Yuan D, et al. Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7. Int J Mol Med. 2019;44(1):157–71. 10.3892/ijmm.2019.4173

11. Hu H, Dong Z, Wang X, Bai L, Lei Q, Yang J, et al. Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma. Onco Targets Ther. 2019;12:5163–75. 10.2147/ott.s183558

12. Girolomoni G, Strohal R, Puig L, Bachelez H, Barker J, Boehncke WH, et al. The role of IL-23 and the IL-23/T(H) 17 immune axis in the pathogenesis and treatment of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(10):1616–26. 10.1111/jdv.14433

13. Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest. 2012;122(2):440–7. 10.1172/jci57416

14. Elias PM, Wakefield JS. Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol. 2014;134(4):781–91.e1. 10.1016/j.jaci.2014.05.048

15. Mizutani Y, Mitsutake S, Tsuji K, Kihara A, Igarashi Y. Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie. 2009;91(6):784–90. 10.1016/j.biochi.2009.04.001

16. Sassa T, Kihara A. Metabolism of very long-chain fatty acids: Genes and pathophysiology. Biomol Ther (Seoul). 2014;22(2):83–92. 10.4062/biomolther.2014.017

17. Miao X, Xiang Y, Mao W, Chen Y, Li Q, Fan B. TRIM27 promotes IL-6-induced proliferation and inflammation factor production by activating STAT3 signaling in HaCaT cells. Am J Physiol Cell Physiol. 2020;318(2):C272–c81. 10.1152/ajpcell.00314.2019

18. Bae HC, Jeong SH, Kim JH, Lee H, Ryu WI, Kim MG, et al. RIP4 upregulates CCL20 expression through STAT3 signalling in cultured keratinocytes. Exp Dermatol. 2018;27(10):1126–33. 10.1111/exd.13750

19. Tang X, Liu Y, Xiao Q, Yao Q, Allen M, Wang Y, et al. Pathological cyclic strain promotes proliferation of vascular smooth muscle cells via the ACTH/ERK/STAT3 pathway. J Cell Biochem. 2018;119(10):8260–70. 10.1002/jcb.26839

20. Chen JG, Fan HY, Wang T, Lin LY, Cai TG. Silencing KRT16 inhibits keratinocyte proliferation and VEGF secretion in psoriasis via inhibition of the ERK signaling pathway. Kaohsiung J Med Sci. 2019;35(5):284–96. 10.1002/kjm2.12034

21. Zhao R, He H, Zhu Y, Wan J, Li Y, Gao S, et al. MiR-204/14-3-3ζ axis regulates osteosarcoma cell proliferation through SATA3 pathway. Pharmazie. 2017;72(10):593–8. 10.1692/ph.2017.7574

22. Cheng X, Wan QL, Li ZB. AG490 suppresses interleukin-34--mediated osteoclastogenesis in mice bone marrow macrophages. Cell Biol Int. 2017;41(6):659–68. 10.1002/cbin.10771

23. Ryu WI, Lee H, Bae HC, Jeon J, Ryu HJ, Kim J, et al. IL-33 down-regulates CLDN1 expression through the ERK/STAT3 pathway in keratinocytes. J Dermatol Sci. 2018;90(3):313–22. 10.1016/j.jdermsci.2018.02.017

24. Gendrisch F, Esser PR, Schempp CM, Wölfle U. Luteolin as a modulator of skin aging and inflammation. BioFactors. 2021;47(2):170–80. 10.1002/biof.1699

25. Qin K, Han C, Zhang H, Li T, Li N, Cao X. NAD(+) dependent deacetylase Sirtuin 5 rescues the innate inflammatory response of endotoxin tolerant macrophages by promoting acetylation of p65. J Autoimmun. 2017;81:120–9. 10.1016/j.jaut.2017.04.006